Showing 3571-3580 of 4262 results for "".
- Metal Implants May Cause Nickel Hypersensitivityhttps://practicaldermatology.com/news/metal-implants-may-cause-nickel-hypersensitivity/2461614/Dermatologists are seeing more patients concerned about a possible skin hypersensitivity to the nickel or other metals used in implanted medical devices. Millions of people in the U.S. report having a metal allergy, and current estimates state that 10 percent of Americans will receive a
- Let There Be Light: Lumohs Founder Donates Scalpels to Floating Doctorshttps://practicaldermatology.com/news/let-there-be-light-lumohs-founder-donates-scalpels-to-floating-doctors/2461595/Floating Doctors will be using the Lumohs scalpel when treating underserved patients in areas without electricity or water. The Floating Doctors' volunteer medical teams deploy by boat, packhorse, or on foot to remote underserved areas. The Lumohs is a pate
- Bristol Myers Squibb Advances Melanoma Drug Candidate Opdivo in US and Europehttps://practicaldermatology.com/news/bristol-myers-squibb-advances-melanoma-drug-candidate-opdivo-in-us-and-europe/2461583/Bristol Myers Squibb announced that the FDA has accepted the supplemental Biologics License Application (BLA) for Opdivo (nivolumab) as monotherapy in the adjuvant setting for the treatment of patients with completely resected stage IIB or IIC melanoma. The company also announced t
- Hydrafacial X Omorovicza Collab: Advanced Skin Renewal Boosterhttps://practicaldermatology.com/news/hydrafacial-x-omorovicza-collab-advanced-skin-renewal-booster/2461569/The Beauty Health Company’s Hydrafacial is rolling out a new booster co-created with Hungarian skincare brand Omorovicza. The booster, available immediately to Hydrafacial providers in North America and EMEA, leverages Omorovicza’s patented Healing Concentrate for a mo
- Eye on the AD Pipeline: Dermavant Completes Enrollment of Phase 3 Trials of VTAMA in Adults and Children with ADhttps://practicaldermatology.com/news/eye-on-the-ad-pipeline-dermavant-completes-enrollment-of-phase-3-trials-of-vtama-in-adults-and-children-with-ad/2461561/Dermavant Sciences has completed patient enrollment in its ADORING 1 and 2 Phase 3 clinical trials of VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children as young as 2 years old. VTAMA cream is a novel, aryl hydrocarbon receptor agonist
- Povorcitinib Produces Lasting Results in HShttps://practicaldermatology.com/news/povorcitinib-produces-lasting-results-in-hs/2461557/Longer-term treatment with povorcitinib 75 mg resulted in sustained and durable efficacy across all treatment arms in a phase 2 study of hidradenitis suppurativa (HS) patients. Povorcitinib is an oral JAK1 inhibitor. These data were presented as an oral presentation at th
- Medical Groups Offer Updated Guidance on Hand Hygiene in Healthcare Settingshttps://practicaldermatology.com/news/groups-offer-updated-guidance-on-hand-hygiene-in-healthcare-settings/2461551/Five medical organizations are recommending updated best practices for hand hygiene to protect patients and staff in healthcare settings. The new recommendations emphasize the importance of healthy skin and nails and easy access to alcohol-based hand sanitizers. Strategi
- NRS Announces 2023 Rosacea Awareness Month Theme: Give New Treatments Time to Workhttps://practicaldermatology.com/news/nrs-announces-2023-rosacea-awareness-month-theme-give-new-treatments-enough-time-to-work/2461547/This Rosacea Awareness Month, the National Rosacea Society (NRS) is highlighting the importance of consistency and patience when trying new therapies. “Rosacea has no cure, but the signs and symptoms can go into remission through a combination of medical therapy and life
- MTX Use May Up Risk for Three Types of Skin Cancerhttps://practicaldermatology.com/news/mtx-use-may-up-skin-cancer-risk/2461546/Methotrexate (MTX) may increase risk for three types of skin cancer, according to a new study out of University of Gothenburg. Patients receiving the drug include those with moderate to severe psoriasis; but in this particular patient group, a risk increase was only observed for basal c
- Merz Aesthetics, NWSL’s North Carolina Courage Expand Partnershiphttps://practicaldermatology.com/news/merz-aesthetics-partners-with-wsls-north-carolina-courage-to-fuel-confidence-on-and-off-field/2461532/Merz Aesthetics is expanding its sponsorship of the North Carolina Courage, two-time champions of the National Women’s Soccer League (NWSL). “This partnership is so meaningful for us at Merz Aesthetics,” says Patrick Urban, North America President, in